IL-PRICEFX
Pricefx , the global leader in native cloud pricing software, today introduced Lightning , the first turnkey solution to enable rapid activation of pricing excellence. Powered by Pricefx Accelerators, Lightning delivers a full suite of standard pricing analytics, management and CPQ realization tools, able to go live in six weeks or less. Customers can accelerate their Pricefx implementation with fast, easy to deploy, pre-configured pricing capabilities.
Businesses are increasingly considering pricing software as a way to navigate the current economic climate. Yet when trying to improve their enterprise pricing approach, customers can face a steep climb to reach activation.
“In my experience, it’s not uncommon for companies to struggle getting started with pricing software,” said Robert Kugel, Senior Vice President and Research Director at Ventana Research. “Starting with a blank whiteboard and getting all stakeholders to agree on the strategy, rules, fundamental approaches and a budget can derail a project before it gets off the ground. With Lightning, Pricefx is attempting to address these challenges by offering pre-configured pricing capabilities out of the box. Using a point-click-deploy approach, Pricefx Lightning is designed to significantly reduce the barriers to adopting a full scope pricing solution.”
Pricefx Lightning offers industry standard, pre-configured foundations for analytics dashboards, pre-defined yet flexible pricing strategies, and instant communication to the field. Removing the friction from implementing a full scope pricing solution, Pricefx offers a point-click-deploy approach designed to empower users who only need to add data to get started. This allows organizations to start the process from the halfway point, skipping weeks or months working through initial configurations.
Once up and running, Pricefx enables users to refine and customize focused on their specific business needs, removing costly proof of concept cycles spent on defining basic requirements. Powered by Pricefx PriceAnalyzer and Sales Insights Accelerator, Lightning provides a powerful pre-configured data analytics environment of out-of-the-box dashboards with more than a dozen optional additional configurations. To gain pricing insights, users simply load their data and start seeing new opportunities for growth and improvement.
To activate analytics-powered insights, Pricefx Lightning provides a robust price setting and management capability connected directly into the customer’s analytics, making the implementation of new intelligence seamless and instant. The analytics and management are natively integrated into the platform, which allows the strategy to be delivered to the field organization in real time. Pricefx pricing platform uses a full featured CPQ including standard workflows, in-line approvals, chat and e-signature support, removing any barriers to delivering pricing excellence.
“Lightning is a first-of-its-kind, tech-enabled fast lane for pricing excellence, designed to supercharge your implementation without breaking the bank,” said Marcin Cichon, CEO and co-founder at Pricefx. “At the outset of this initiative, our goal was to skip the POC stage and get customers working with a live product. We believe that by delivering out-of-the-gate value Pricefx can provide an informed launch point that enables businesses to focus on enhancements that create a competitive advantage and build organizational alignment with real data and results. With Lightning, we can dramatically accelerate time-to-value and have customers running live in six weeks – no one else on the market can deliver that.”
Lightning is the result of 18 months of work, with dozens of customers in more than 10 vertical industries. Its broad, versatile and flexible standard set of pre-configurations are designed to meet the analytics, management and realization needs of any organization looking to rapidly improve their entire pricing capability.
Lightning is free to activate through June 2020 with a signed subscription agreement for the three modules that power the solution – PriceAnalyzer , PriceBuilder and QuoteConfigurator . Interested customers should contact their current Pricefx representative for more information .
About Pricefx
Established in 2011 in Germany, Pricefx is the global leader in SaaS pricing software, offering a comprehensive suite of solutions that are fast to implement, flexible to configure and customize, and friendly to learn and use. Pricefx delivers a complete price optimization and management platform based on native cloud architecture, providing industry leading time to value and total cost of ownership advantages to customers. Their innovative solution works for both B2B and B2C enterprises of any size, in any industry, in any part of the world. Pricefx’s business model is entirely based on the satisfaction and loyalty of its customers. Today, Pricefx delivers Passion for Pricing to more than 100 customers in more than 37 countries worldwide. For more information, please visit www.pricefx.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200514005236/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom